Skinopathy Files Provisional Patent for Artificial Intelligence and Augmented Reality Powered Technology that will Guide Skin Cancer Surgeries
02 févr. 2021 10h30 HE
|
Skinopathy
TORONTO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Skinopathy, a Canadian medical company founded in 2020, has filed a provisional patent with the United States Patent and Trademark Office (USPTO) for...
AiViva Biopharma Initiates Phase 1/2 Clinical Trial of AIV001 for Nonmelanoma Skin Cancer
02 oct. 2020 08h00 HE
|
AiViva Biopharma
NEWPORT BEACH, Calif., Oct. 02, 2020 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has begun dosing patients diagnosed with superficial or...